Market revenue in 2024 | USD 22.4 million |
Market revenue in 2030 | USD 41.6 million |
Growth rate | 11% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 71.88% in 2024. Horizon Databook has segmented the Netherlands deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
The deep brain stimulation devices market in the Netherlands is projected to exhibit steady growth rate during the forecast period. The growth can be attributed to increase in geriatric population and the rise in the need for advancements in healthcare system.
Moreover, various research initiatives undertaken by medtech startup companies to develop brain stimulation devices are expected to fuel the market growth in the coming years.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account